Efficient Identification and Referral of Low-Income Women at High Risk for Hereditary Breast Cancer: A Practice-Based ApproachJoseph G.a, d · Kaplan C.b · Luce J.b · Lee R.c · Stewart S.e · Guerra C.d · Pasick R.b, d
Departments of aAnthropology, History and Social Medicine, and bMedicine, cCancer Risk Program, and dHelen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, Calif., and eDepartment of Public Health Sciences, University of California, Davis, Davis, Calif., USA Corresponding Author
Galen Joseph, PhD
University of California, San Francisco
1450 3rd Street, Room 551
San Francisco, CA 94158-9001 (USA)
Tel. +1 415 514 9421, E-Mail email@example.com
Background: Identification of low-income women with the rare but serious risk of hereditary cancer and their referral to appropriate services presents an important public health challenge. We report the results of formative research to reach thousands of women for efficient identification of those at high risk and expedient access to free genetic services. External validity is maximized by emphasizing intervention fit with the two end-user organizations who must connect to make this possible. This study phase informed the design of a subsequent randomized controlled trial. Methods: We conducted a randomized controlled pilot study (n = 38) to compare two intervention models for feasibility and impact. The main outcome was receipt of genetic counseling during a two-month intervention period. Model 1 was based on the usual outcall protocol of an academic hospital genetic risk program, and Model 2 drew on the screening and referral procedures of a statewide toll-free phone line through which large numbers of high-risk women can be identified. In Model 1, the risk program proactively calls patients to schedule genetic counseling; for Model 2, women are notified of their eligibility for counseling and make the call themselves. We also developed and pretested a family history screener for administration by phone to identify women appropriate for genetic counseling. Results: There was no statistically significant difference in receipt of genetic counseling between women randomized to Model 1 (3/18) compared with Model 2 (3/20) during the intervention period. However, when unresponsive women in Model 2 were called after 2 months, 7 more obtained counseling; 4 women from Model 1 were also counseled after the intervention. Thus, the intervention model that closely aligned with the risk program’s outcall to high-risk women was found to be feasible and brought more low-income women to free genetic counseling. Our screener was easy to administer by phone and appeared to identify high-risk callers effectively. The model and screener are now in use in the main trial to test the effectiveness of this screening and referral intervention. A validation analysis of the screener is also underway. Conclusion: Identification of intervention strategies and tools, and their systematic comparison for impact and efficiency in the context where they will ultimately be used are critical elements of practice-based research.
© 2012 S. Karger AG, Basel
It has been common and accepted practice to develop disease-specific prevention and early detection interventions with each having its own dedicated infrastructure, staff and methods. Examples include many community- and clinic-based interventions to encourage breast, cervical or colorectal cancer screening [1,2,3,4]. The purpose of this study was to develop an efficient and sustainable practice-based model to integrate assessment and referral for hereditary breast and ovarian cancer syndrome (HBOC) into an existing communication channel used by large numbers of ethnically diverse low-income women. The primary focus is external validity, development of an intervention by and with end-users, minimizing additions or deviations from actual practice to maximize prospects for implementation .
This article reports the results of a pilot study comparing two approaches for engaging high risk low-income women in free genetic counseling to assess feasibility and fit for the two end-users of the intervention: a single-purpose statewide phone service which receives thousands of calls every year from low-income women for referrals to free cancer screening and an academic/public hospital cancer risk program that delivers free genetic counseling and testing. We also developed and pretested a family history screener because existing tools were not suitable for efficient administration by phone.
Clinical assessment followed by genetic testing of high-risk individuals is the recommended standard of care [5,6,7]. Women with deleterious BRCA mutations have as much as an 85% risk for breast cancer and 45% risk for ovarian cancer over the course of their lifetime compared with 12.2% for women in the general population [8,9,10]. Counseling, screening, treatment, and preventive measures associated with BRCA testing have been shown to reduce morbidity and mortality and to improve quality of life [10,11,12,13,14,15,16,17,18,19]. A 2009 Cochrane review found that ‘cancer genetic risk assessment is beneficial’ for patients at risk of HBOC by reducing psychological distress and worry about breast cancer, improving accuracy of risk perception and increasing knowledge of breast cancer and genetics; ‘however, more studies are required to assess the best means of delivering these services by different health professionals and in alternative locations, through a variety of interventions’. Thus, there is a clear need for efficient large-scale risk assessment in order to identify the small number of women who should be referred to genetic counseling.
Until recently, however, low-income women have not had the benefit of outreach or education on HBOC, nor have genetic counseling and testing for HBOC been widely available to them because there was no source of free or low-cost service. While the prevalence of BRCA mutations is similar across US ethnic groups (with the exception of individuals with Ashkenazi Jewish ancestry), fewer than 13% of all women who receive BRCA testing are of non-European ancestry even though people of color, who are disproportionately low-income, make up 35% of the US population [20,21,22,23,24]. According to a review by Halbert et al. , the methods typically used to enroll women in risk assessment – including self-referral or referral by a physician, usually at the prompting of a patient – are less likely to occur among African American women and women of other groups who are known to have lower levels of knowledge and awareness of genetic counseling and testing .
Several assessment tools have been designed to predict likelihood of a BRCA mutation and thus appropriate ness for genetic testing (e.g. BRCAPRO, Myriad II, BOADICEA, PENN II) [27,28,29,30,31,41]. However, there is no standard tool for determining referral to genetic counseling. Eligibility for genetic testing requires a complete pedigree, including enumeration of family members who have and have not had cancer, types of cancer and age at diagnosis. In contrast, identification of those who should be referred to obtain such a pedigree is based on a set of ‘red flags’ such as breast cancer before age 50, breast and ovarian cancer, bilateral breast cancer, and/or male breast cancer.
The central premise of this study is that low-income women should have ready access to genetic risk assessment and that the strategies to make this possible must be sustainable and thus not require extraordinary measures or the creation of entirely new infrastructure. Ideally they should fit into existing structures and resources with minimal modification to personnel and procedures [32,33,34]. Our intervention has two end-users, the California Department of Health Services Every Woman Counts program (EWC), a toll-free telephone service that provides statewide referrals to free breast and cervical cancer screening with funding from the Centers for Disease Control and a state tobacco tax, and the University of California San Francisco (UCSF) Cancer Risk Program (CRP) with sites on campus and at San Francisco General Hospital (SFGH), the public hospital for the City and County of San Francisco. Through donor funds at UCSF and with support from the Avon Foundation at SFGH, free genetic counseling and testing is offered to low-income women from around the Bay Area. Our intervention is designed to identify low-income Bay Area EWC callers at high risk and refer them to UCSF or SFGH for free genetic services and to seamlessly fit this new service into the policies and procedures of each setting.
We recognized the EWC phone service as a potentially novel channel for reaching low-income women for varied preventive services based on a pilot study in which 49.5% of eligible callers were willing to participate in research on a topic unrelated to the purpose of their call . Qualitative data from that study suggested that the unexpectedly high rate of participation was due to the trust engendered by EWC’s provision of free screening, its multi-lingual capability and promotion of the service through credible local media. Based on this finding, we designed the current study to assess the potential of this communication channel to identify callers who are at high risk for breast/ovarian cancer and to refer them to genetic counseling/testing services. (To further explore this approach, we also tested the willingness of Asian American callers to discuss Hepatitis B testing ).
The study has 2 phases: Phase I, the focus of this report, consists of 2 components: (a) development and pretest of the Six-Point Scale family history screener and (b) an intervention pilot test comparing 2 models for integrating the risk identification and genetic counseling services: the EWC for access to large numbers of women and administration of a risk screener and the UCSF CRP for provision of free counseling and testing. Study components were reviewed and approved by the institutional review boards of the UCSF and Cancer Prevention Institute of California (where EWC is housed).
Study participants were recruited among callers to EWC. At the start of every call, Information Specialists collect demographic and contact information and enter it into a computer program. We adapted the program to identify eligible women using these criteria: county of residence (for proximity to the CRP), language of call (English or Spanish) and age (25 and over, the ages usually served by the CRP). At the conclusion of usual service, the Specialist invited study-eligible women to participate and conducted a short verbal consent.
A key component of our intervention is a risk assessment tool that met the following criteria: (1) ease of use over the phone by EWC Information Specialists whose level of training (typically high school graduates) allowed only for asking simple straightforward questions and (2) brevity because the risk assessment and genetic counseling referral followed the EWC usual call service consisting of eligibility assessment and referral for cancer screening. When we began our study, only 2 tools were available to assess eligibility for genetic counseling, the Pedigree Assessment Tool (PAT), a web-based scoring system [37,38] and the Family History Assessment Tool (FHAT), both designed for use by clinicians. Both tools are overly complex for our purposes because they include second- and third-degree relatives and calculate separate scores for maternal and paternal family history. The FHAT also takes into account multiple categories for age at diagnosis and the type/number of primary cancers (bilateral, multifocal, breast/ovarian in a single individual).
To develop a more parsimonious screening tool, we adapted and simplified the PAT calling the new tool the ‘Six-Point Scale’ (fig. 1). Adaptation included identification of the minimum family history criteria for appropriate referral to cancer risk assessment and development of a weighting scheme that scored responses according to risk (i.e. higher risk responses, such as first-degree relative diagnosed under age 50 or male breast cancer, were assigned higher scores). A threshold of 6 points indicated referral to genetic counseling. A genetic counselor conducted a preliminary test of the scale using the pedigrees of 7 genetic counseling patients to complete both the Six-Point and PAT scales and finding that the resulting scores appropriately qualified the patients for genetic counseling.
Like the PAT, the Six-Point Scale includes a series of questions, each with a weighted score. However, for the Six-Point Scale, respondents need only answer questions up to a total score of 6, at which point the EWC computer program identifies callers as eligible for genetic counseling. The Six-Point Scale is further streamlined because it does not separately assess maternal and paternal lineages or include third-degree relatives, making it simpler for the staff administering it and the respondent. Since beginning our study, one validated genetic counseling referral tool has been published [40,41]. The Referral Screening Tool (RST) also simplifies the screening process, consisting of a one-page table scored with a series of checks. However, all questions must be answered to arrive at a score. Table 1 summarizes and compares the features of the 4 scales.
During development, we could not determine whether there was an advantage to beginning the questionnaire with a broad question that would reduce the number of respondents but which might be more difficult to answer, ‘Have you or any of your blood relatives on your mother or father’s side had breast or ovarian cancer?’ We suspected such a question would increase the length of the call and the burden on Information Specialists. To ascertain the more efficient structure, we pretested 2 versions of the Six-Point Scale for ease of administration. The primary differences were the initial question and question order. Version 1 asks family history questions in a logical order beginning with the caller and then her closest to least close but still relevant relatives (mother, sisters, grandmothers, aunts) and asks about more common cancers first (breast before ovarian cancer). Version 2, in addition to beginning with the broad question mentioned above, asks the highest scoring questions first (e.g. ovarian cancer before breast cancer question).
To complete 20 pretests, eligible callers were consented, randomized to one version (10 callers each with 5 English and 5 Spanish-speaking respondents) and asked the corresponding questions. Brief cognitive interviews with EWC callers were conducted by study staff within 24 h of the EWC call, and debrief interviews with the 2 participating Specialists were conducted immediately following each pretest call session. Participants received a USD 20 gift card in appreciation for their time. Women identified as low risk via the screener were sent a flier after completion of the pretest with information about where to call if they had questions about their hereditary cancer risk. Women identified as high risk via the screener were sent an informational brochure and called by the UCSF CRP with an offer of free genetic counseling. The version of the scale found easiest to use has been implemented in the subsequent intervention pilot test and is undergoing a validation analysis.
We identified 2 different approaches for encouraging high-risk women to obtain genetic counseling, each being more compatible with one of the 2 systems involved (the EWC phone service or the UCSF/SFGH CRP). Also, one required more staff effort while the other asked more of participants. Model 1 fits the CRP usual practice where referrals containing family history or personal medical history information are received from other clinics. These patients are called by a genetic counseling assistant and offered a counseling appointment. Thus, in Model 1, callers to EWC were told, ‘Your answers [to our family history questions] show that it may be useful for you to talk with a genetic counselor. If you are interested in doing that, I can give your contact information to a genetic counselor at the Cancer Risk Program. The counselor will call you within 1 week to invite you to a free genetic counseling session, so you can learn more about what the cancer in your family means for you. Do you want the counselor to call you?’
Model 2 fits with EWC usual practices. EWC assesses eligibility and provides referrals to free mammograms and pap tests, and women are responsible for obtaining those services on their own. In Model 2, callers were told, ‘Your answers show that it may be useful for you to talk with a genetic counselor. If you like, I will give you the contact information for the Cancer Risk Program where you can get free genetic counseling, so you can learn more about what the cancer in your family means for you. In addition, we will send you a brochure with more information and the contact information for the Cancer Risk Program. The counselor will be expecting your call. We strongly encourage you to call her.’ EWC managers pointed out that phone service staff are not trained to discuss technical medical issues with callers and thus, initially preferred Model 2 because it deferred basic questions to the UCSF genetic counseling assistants who are trained to discuss basic concepts about family history and genetic counseling.
Because fit is a priority for this study, we conducted a pilot test to compare the ease of administration and impact of 2 strategies among 38 high-risk callers. An additional goal of the pilot test was to examine these interventions without the potential bias that can be introduced by administration of a baseline survey. (In the main intervention trial, baseline and post-intervention surveys are used to assess changes in anxiety, knowledge and cancer worry due to the intervention and due to attending genetic counseling.)
For the pilot test, the Six-Point Scale was administered to eligible consenting callers following usual EWC services. Those who were not candidates for genetic counseling (scoring 5 or lower on the screener) were told their answers indicated no need to speak with a genetic counselor, but that they would receive a brochure in the mail with additional information and a contact number for a genetic counselor at UCSF if they had questions. Women who scored 6 or higher (‘high-risk callers’) were randomly assigned by the computer to Model 1 or Model 2 (fig. 2). Two months following randomization, women in Model 2 who had not yet sought or obtained counseling were called by genetic counseling assistants. This two-month interval was considered the ‘intervention period’.
The debrief interviews with EWC Information Specialists indicated that both screeners were easy to use and that the callers did not have difficulty answering the questions. Callers also did not ask technical or medical questions that the Specialists were unprepared to answer. As we expected, for callers who responded ‘no’ to the first question on Screener #2 ‘Have you or any of your blood relatives on your mother or father’s side had breast or ovarian cancer?’ the screening process was shorter since that was the only question they needed to answer. For respondents, who answered ‘yes’ to that first question, Specialists reported that the time to completion was comparable to that for Screener #1. While Screener #2 was thus faster to use than Screener #1 for some callers, Specialists reported that it did not allow them sufficient time to develop rapport with the caller. One Specialist said that Screener #1 ‘allows time for the caller to see that they [EWC] really care about them.’ The Specialists also indicated that Screener #2 did not allow sufficient time for callers to think through the cancer history of various family members.
The debrief interviews with callers showed that the genetic screener questions were easy to understand and to answer, although some participants indicated that they were not sure of their family history and that this uncertainty was a concern. Most participants reported that answering questions about family history of cancer over the phone in the context of the EWC call was comfortable.
The 38 participants in the intervention pilot test ranged in age from 25 to 64, with an average age of 47.8. Participants were ethnically diverse: 15 (39%) Hispanic, 13 (34%) White, 5 (13%) African American, 4 (11%) Asian/Pacific Islander, and 1 (2%) unknown. Among Hispanic participants, 5 were Spanish speakers and 10 spoke English. Most participants had either completed high school (39%) or some college (29%). Among the others, 3 (7%) had completed grade school, 7 (18%) were college graduates and 2 (5%) had some postgraduate training.
Overall, 17 out of 38 women (45%) obtained genetic counseling. This included 7 women from Model 1 and 10 from Model 2, a difference that is not statistically significant. There were also no significant differences in counseling by race/ethnicity or language: those counseled included 2 of 5 African Americans, 2 of 4 Asian/Pacific Islanders, 5 of 15 Hispanics, 7 of 13 Whites, and 1 of unknown race/ethnicity. English speakers numbered 33, of whom 15 were counseled; 2 of 5 Spanish speakers obtained counseling. During the intervention period, 3 out of 18 women in Model 1 obtained counseling compared to 3 out of 20 for Model 2, also a nonsignificant difference. Of note is the fact that the majority of Model 1 women were contacted within 3 days of randomization, but for 3 women it took between 20 days and 4 months to make the initial contact after randomization. Women never counseled included those who could not be reached after numerous attempts (9), those who declined counseling (5), and those who initiated but never completed the appointment scheduling process (7).
Reports from both end-user organizations noted that the process went smoothly for each.
The primary components of our intervention are: (a) the EWC phone service that attracts diverse low-income women; (b) a screening tool that can be administered over the phone by minimally trained staff; and (c) free genetic counseling and testing in a system designed to reach out to low-income women, routinely calling and offering genetic counseling. The purpose of the formative research was to link EWC and the CRP and simultaneously to minimize organizational burden and cost, and to maximize identification of high-risk women and their subsequent use of genetic counseling. We also developed and pretested a family history screener that efficiently identifies high-risk women by telephone.
Our findings indicate considerable receptivity among low-income and ethnically diverse women when offered the opportunity to discuss their family history and, if found to be eligible for genetic counseling, a similarly high degree of willingness to take advantage of the services. Our results underscore the necessity of calling high-risk low-income women to offer genetic counseling. This is particularly evident from Model 2 where only 3 high-risk women sought counseling on their own. Yet, 7 more women randomized to that arm subsequently obtained counseling once they were called. This contrasts with more affluent/insured women who are known to self-refer to genetic counseling. Thus, Model 1 was deemed the preferred strategy and is currently being tested for effectiveness in a larger randomized controlled trial.
Identification of intervention strategies and tools, and their systematic comparison for impact and efficiency in the context where they will ultimately be used is informative and desirable for practice-based research. In the words of Lawrence W. Green, ‘If you want more evidence-based practice, you need more practice-based evidence’. .
Reaching out to low-income women to identify those at high risk for hereditary breast cancer can feasibly be integrated into a communication channel already widely used by this population and can readily connect them to academic and public hospital-based genetic services. This is critical since these are potentially very high-risk women who would otherwise not access these life-saving services. Toll-free phone lines that provide information and referral for free breast and cervical screening may be ideally suited for this purpose.
Support for this research comes from the National Cancer Institute, 1R01CA129096 PI: Dr. Rena Pasick. We also wish to acknowledge the Avon Foundation and the National Breast Cancer Foundation for resources to provide life-saving services to low-income women.
Galen Joseph, PhD
University of California, San Francisco
1450 3rd Street, Room 551
San Francisco, CA 94158-9001 (USA)
Tel. +1 415 514 9421, E-Mail firstname.lastname@example.org
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.